Litcius/Paper detail

O-GlcNAc Signaling Augmentation Protects Human Corneal Endothelial Cells from Oxidative Stress via AKT Pathway Activation

Chang Ki Yoon, Sam Young Yoon, Jin Sun Hwang, Young Joo Shin

2020Current Eye Research12 citationsDOI

Abstract

Purpose: To investigate the effect of inhibitor of O-glycosylation on human corneal endothelial cells (HCECs) under oxidative stress.Methods: HCECs were cultured and treated with 10 mM tert-butyl hydroperoxide (tBHP) with or without PUGNAc, a known inhibitor of OGA. Cell viability was assessed. Mitochondrial membrane potential (ΔΨm) was measured. Intracellular Ca2+ levels and mitochondrial Ca2+ levels were measured. Intracellular reactive oxygen species formation was measured. Levels of O-linked β-N-acetylglucosamine (O-GlcNAc), AKT, and pAKT were evaluated by Western blotting.Results: O-GlcNAc augmentation by PUGNAc increased cell viability, attenuated the loss of ΔΨm, and intracellular ROS against tBHP-induced oxidative stress (p < .05). O-GlcNAc augmentation reduced tBHP-induced mitochondrial calcium overload (p < .05) while it did not have any effect on intracellular calcium overload with tBHP. Furthermore, AKT signaling was activated in the cells with O-GlcNAc augmentation.Conclusions: O-GlcNAc signaling augmentation protects HCECs from oxidative stress via activation of AKT pathways.

Topics & Concepts

Oxidative stressIntracellularProtein kinase BReactive oxygen speciesViability assayChemistryCell biologyOxidative phosphorylationCalcium in biologyMitochondrionApoptosisPI3K/AKT/mTOR pathwayBiochemistryBiologyGlycosylation and Glycoproteins ResearchAdvanced Glycation End Products researchGlaucoma and retinal disorders